| RS1486270427 |
KIZ
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurodevelopmental disorder, mitochondrial |
| RS1486271481 |
SLC52A3
|
Health Risk |
Pathogenic |
Brown-Vialetto-van Laere syndrome 1, Brown-Vialetto-van Laere syndrome 1 |
| RS1486280029 |
GCK
|
Health Risk |
Pathogenic/Likely pathogenic |
Maturity-onset diabetes of the young type 2, Monogenic diabetes |
| RS148628141 |
ACTN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1AA, Primary familial hypertrophic cardiomyopathy |
| RS148628152 |
KIF22
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS148629796 |
ITGB4
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1486299333 |
WDPCP
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS148630223 |
COL6A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Collagen 6-related myopathy, Bethlem myopathy 1A |
| RS148630367 |
NIN
|
Health Risk |
Conflicting classifications of pathogenicity |
NIN-related disorder, NIN-related disorder |
| RS1486303961 |
DYSF
|
Health Risk |
Pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS148631462 |
FGFR3
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS148631577 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS148632434 |
RNF168
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS148633216 |
MSH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, MSH3-related disorder |
| RS1486335553 |
ANO5
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2L, Gnathodiaphyseal dysplasia |
| RS148634289 |
SDHD
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary pheochromocytoma and paraganglioma |
| RS148634904 |
SH3TC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 4, Susceptibility to mononeuropathy of the median nerve |
| RS1486350523 |
ACADM
|
Health Risk |
Pathogenic |
Medium-chain acyl-coenzyme A dehydrogenase deficiency, Medium-chain acyl-coenzyme A dehydrogenase deficiency |
| RS148636080 |
COL4A6
|
Health Risk |
Conflicting classifications of pathogenicity |
COL4A6-related disorder, COL4A6-related disorder |
| RS148636776 |
SH2B3
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary familial polycythemia due to EPO receptor mutation, Thrombocythemia 1 |
| RS1486368788 |
PRKCG
|
Health Risk |
Likely pathogenic |
Hereditary ataxia, Hereditary ataxia |
| RS148636883 |
AHNAK
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS148637748 |
SSR4
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS148637820 |
PPP6R2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS148637964 |
MRE11
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia-like disorder 1 |
| RS148638156 |
COL7A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Epidermolysis bullosa dystrophica, Inborn genetic diseases |
| RS148638616 |
TBCEL-TECTA;TECTA
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant nonsyndromic hearing loss 12, Autosomal recessive nonsyndromic hearing loss 21 |
| RS148639841 |
ACAT1
|
Health Risk |
Pathogenic/Likely pathogenic |
Deficiency of acetyl-CoA acetyltransferase, ACAT1-related disorder |
| RS148640214 |
ACADSB
|
Health Risk |
Conflicting classifications of pathogenicity |
Deficiency of 2-methylbutyryl-CoA dehydrogenase, Deficiency of 2-methylbutyryl-CoA dehydrogenase |
| RS148640446 |
GSS
|
Health Risk |
Conflicting classifications of pathogenicity |
Inherited glutathione synthetase deficiency, GSS-related disorder |
| RS148641194 |
FAT2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS148641361 |
ITGA7
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital muscular dystrophy due to integrin alpha-7 deficiency, ITGA7-related disorder |
| RS148641800 |
EPG5
|
Health Risk |
Conflicting classifications of pathogenicity |
Vici syndrome, EPG5-related disorder |
| RS148641957 |
KDM6B
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, KDM6B-related disorder |
| RS148642064 |
PMS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS148642741 |
UBA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Infantile-onset X-linked spinal muscular atrophy, Inborn genetic diseases |
| RS1486435006 |
F8
|
Health Risk |
Likely pathogenic |
— |
| RS148643501 |
WDR72
|
Health Risk |
Conflicting classifications of pathogenicity |
Amelogenesis imperfecta hypomaturation type 2A3, Amelogenesis imperfecta hypomaturation type 2A3 |
| RS148643665 |
DMD
|
Health Risk |
Conflicting classifications of pathogenicity |
Duchenne muscular dystrophy, Becker muscular dystrophy |
| RS148644578 |
NBAS
|
Health Risk |
Conflicting classifications of pathogenicity |
NBAS-related disorder, NBAS-related disorder |
| RS148644997 |
COPB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1486450052 |
SACS
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia, Spastic paraplegia |
| RS1486452597 |
DOCK8
|
Health Risk |
Likely pathogenic |
Combined immunodeficiency due to DOCK8 deficiency, Combined immunodeficiency due to DOCK8 deficiency |
| RS1486454956 |
ANKRD11
|
Health Risk |
Conflicting classifications of pathogenicity |
KBG syndrome, KBG syndrome |
| RS1486460574 |
SETBP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, SETBP1-related disorder |
| RS1486461236 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS148646143 |
DNMT3B
|
Health Risk |
Conflicting classifications of pathogenicity |
Immunodeficiency-centromeric instability-facial anomalies syndrome 1, Centromeric instability of chromosomes 1 |
| RS148646265 |
ACTN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1AA, Primary familial hypertrophic cardiomyopathy |
| RS1486464304 |
PKP2
|
Health Risk |
Pathogenic |
Arrhythmogenic right ventricular dysplasia 9, Arrhythmogenic right ventricular dysplasia 9 |
| RS148646547 |
SPRED1
|
Health Risk |
Pathogenic |
Legius syndrome, Legius syndrome |
| RS148646968 |
DOLK
|
Health Risk |
Conflicting classifications of pathogenicity |
DK1-congenital disorder of glycosylation, Cardiovascular phenotype |
| RS148647206 |
PALB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS148647933 |
EYA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Branchiootic syndrome 1, Otofaciocervical syndrome 1 |
| RS148647954 |
CD3E
|
Health Risk |
Conflicting classifications of pathogenicity |
Immunodeficiency 18, Immunodeficiency 18 |
| RS1486482604 |
KCNV2
|
Health Risk |
Pathogenic/Likely pathogenic |
Cone dystrophy with supernormal rod response, Cone dystrophy with supernormal rod response |
| RS148648480 |
LAMB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Pierson syndrome, LAMB2-related infantile-onset nephrotic syndrome |
| RS148649390 |
HOXB13
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, HOXB13-related disorder |
| RS148649507 |
SEMA3E
|
Health Risk |
Conflicting classifications of pathogenicity |
CHARGE syndrome, SEMA3E-related disorder |
| RS1486504113 |
DOCK8
|
Health Risk |
Pathogenic |
Combined immunodeficiency due to DOCK8 deficiency, Combined immunodeficiency due to DOCK8 deficiency |
| RS148650935 |
DNAJB13
|
Health Risk |
Conflicting classifications of pathogenicity |
DNAJB13-related disorder, DNAJB13-related disorder |
| RS148651377 |
SIL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Marinesco-Sjögren syndrome, Marinesco-Sjögren syndrome |
| RS148652044 |
MYO6
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant nonsyndromic hearing loss 22, Autosomal recessive nonsyndromic hearing loss 37 |
| RS148652047 |
DYSF
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Inborn genetic diseases |
| RS1486529587 |
AP3B2
|
Health Risk |
Pathogenic |
— |
| RS148653061 |
SLC29A4
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS148653339 |
NEFH
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, NEFH-related disorder |
| RS148653755 |
CEP131
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1486544403 |
NOTCH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS148654588 |
KCNQ2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, KCNQ2-related disorder |
| RS148654834 |
ANK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital long QT syndrome, Long QT syndrome |
| RS1486551074 |
AXIN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Oligodontia-cancer predisposition syndrome, Hereditary cancer-predisposing syndrome |
| RS1486555733 |
CHD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy 94, Developmental and epileptic encephalopathy 94 |
| RS1486560342 |
JAK2
|
Health Risk |
Likely pathogenic |
— |
| RS148656615 |
DNAH11
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia 7, Primary ciliary dyskinesia |
| RS1486566170 |
KLHL40
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 8, Nemaline myopathy 8 |
| RS148656779 |
NDUFA10
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial complex I deficiency, nuclear type 1 |
| RS148657084 |
TRPM6
|
Health Risk |
Conflicting classifications of pathogenicity |
Intestinal hypomagnesemia 1, Intestinal hypomagnesemia 1 |
| RS148657311 |
USH2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 2A, Retinitis pigmentosa |
| RS1486585360 |
TNPO3
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant limb-girdle muscular dystrophy type 1F, Autosomal dominant limb-girdle muscular dystrophy type 1F |
| RS1486594906 |
ATP7B
|
Health Risk |
Pathogenic/Likely pathogenic |
Wilson disease, Wilson disease |
| RS148659928 |
CD96
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS148660051 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 39, Usher syndrome type 2A |
| RS148660170 |
OTC
|
Health Risk |
Conflicting classifications of pathogenicity |
Ornithine carbamoyltransferase deficiency, Inborn genetic diseases |
| RS148660796 |
FBLN5
|
Health Risk |
Conflicting classifications of pathogenicity |
Macular degeneration, age-related |
| RS1486611027 |
IL7
|
Health Risk |
Pathogenic |
Epidermodysplasia verruciformis, susceptibility to |
| RS148661165 |
PDE6C
|
Health Risk |
Conflicting classifications of pathogenicity |
Cone dystrophy 4, Achromatopsia |
| RS148661902 |
KDM5C
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic paraplegia, Spastic paraplegia |
| RS148661980 |
PC
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Pyruvate carboxylase deficiency |
| RS1486622300 |
SLC12A1
|
Health Risk |
Likely pathogenic |
— |
| RS1486623736 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS148662426 |
CIZ1
|
Health Risk |
Conflicting classifications of pathogenicity |
Dystonic disorder, Dystonic disorder |
| RS148662665 |
PIGV
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperphosphatasia with intellectual disability syndrome 1, PIGV-related disorder |
| RS148662747 |
CTNS
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Ocular cystinosis |
| RS1486627670 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS148662935 |
ABCA3
|
Health Risk |
Conflicting classifications of pathogenicity |
Interstitial lung disease due to ABCA3 deficiency, Interstitial lung disease due to ABCA3 deficiency |
| RS1486630796 |
EIF2B1
|
Health Risk |
Pathogenic |
— |
| RS148663427 |
MEGF10
|
Health Risk |
Conflicting classifications of pathogenicity |
MEGF10-related myopathy, MEGF10-related myopathy |
| RS1486636299 |
IFT56
|
Health Risk |
Likely pathogenic |
Biliary, renal |
| RS148663672 |
FRAS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Fraser syndrome 1, FRAS1-related disorder |
| RS148663745 |
IFT140
|
Health Risk |
Conflicting classifications of pathogenicity |
Saldino-Mainzer syndrome, Retinitis pigmentosa 80 |